ATG5 and Cognitive impairment: Accordingly, previous findings showed lower values of ATG5 in serum/plasma samples of AD, mild cognitive impairment (MCI), mixed dementia, and PD subjects [41,42], and a downward trend of ATG5 concentrations in the temporal cortex of AD and DLB patients compared to those in CTRL subjects [43].